-+ 0.00%
-+ 0.00%
-+ 0.00%

Marker Therapeutics Q1 EPS $(0.16) Beats $(0.18) Estimate

Benzinga·05/15/2026 22:08:20
Listen to the news
Marker Therapeutics (NASDAQ:MRKR) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.18) by 11.11 percent. This is a 60 percent increase over losses of $(0.40) per share from the same period last year.